Prosecution Insights
Last updated: May 29, 2026

Acuity Law Group, P.C.

22 pending office actions • 15 clients • 22 examiners • 17 art units • 0 of 22 (0%) have an AI response strategy ready • 42 patents granted in the last 365 days

Portfolio Summary

22
Total Pending OAs
16
Non-Final OAs
6
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 22 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

12
Overdue
0
Due this week
8
Due this month
1
Due in next 60 days
1
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 22 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (12)Due ≤ 30 days (8)Due ≤ 60 days (1)Due later (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
17
Medium (77%)
2
Easy (9%)
3
Unknown (14%)

Rejection Statute Mix

BucketCases
§103 only16 (73%)
§102 only1 (5%)
§112 only2 (9%)
No statute on record3 (14%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

19
Life Sciences
86% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
1
Semiconductors
5% of docket
2
Mechanical / Eng
9% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

220 h
Manual time on pending OAs
44 h
Time saved (low, 20%)
77 h
Time saved (mid, 35%)
1.9 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
WILSON, JERICA KATLYNN 1 60.6% +40.0%
JOHANNSEN, DIANA B 1 53.2% +41.1%
JACKSON III, WALTER 1
GONZALEZ, MADELINE 1 72.4% +15.7%
DIBRINO, MARIANNE 1 43.3% +41.2%
TURK, NEIL N 1 50.9% +44.8%
MARTIN, PAUL C 1 42.0% +21.7%
KIM, YOUNG J 1 64.8% +17.9%
PAK, YONG D 1 74.4% +13.7%
VANN-OJUEKAIYE, KENDRA RAYCHELL 1 0.0% +0.0%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18253272 DETECTING METHYLATION CHANGES IN DNA SAMPLES USING RESTRICTION ENZYMES AND HIGH THROUGHPUT SEQUENCING VANN-OJUEKAIYE, KENDRA RAYCHELL 27d

Interview Candidates (8)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18255791 METHOD OF PRODUCING GLOBIN POLYPEPTIDE RECOMBINANTLY AND MEAT SUBSTITUTE FOOD PRODUCT PAK, YONG D 96d overdue
18407073 KITS AND METHODS FOR DIAGNOSING LUNG CANCER JOHANNSEN, DIANA B 91d overdue
18547489 METHODS OF ISOLATING EXOSOMES GONZALEZ, MADELINE 36d overdue
18262469 ANALYZER AND METHOD FOR READING DETECTION RESULT OF TEST APPARATUS TURK, NEIL N 10d overdue
18236327 T CELL RECEPTORS AND USES THEREOF DIBRINO, MARIANNE 9d
18261995 NON-INVASIVE CANCER DETECTION BASED ON DNA METHYLATION CHANGES KIM, YOUNG J 13d
18262433 METHOD OF CHANGING CULTURE MEDIUM OF A CULTURE USING SPINFILTERS MARTIN, PAUL C 19d
18443904 MEK-INHIBITOR FOR THE TREATMENT OF VIRAL AND BACTERIAL INFECTIONS WILSON, JERICA KATLYNN 23d

Client Portfolio (15 clients)

Top Art Units

Art UnitApps
16822
17982
16532
16812
16712
16211
16381
17731
16411
16521

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
18443904 MEK-INHIBITOR FOR THE TREATMENT OF VIRAL AND BACTERIAL INFECTIONS Atriva Therapeutics GmbH WILSON, JERICA KATLYNN 1621 Other Non-Final OA 23d Pending Feb 16, 2024
18407073 KITS AND METHODS FOR DIAGNOSING LUNG CANCER Nucleix Ltd. JOHANNSEN, DIANA B 1682 §103 Non-Final OA 91d overdue Pending Jan 08, 2024
18289557 METHODS FOR STIMULATING AND TRANSDUCING T CELLS C3S2 GmbH JACKSON III, WALTER 1638 §102 Non-Final OA 15d overdue Pending Nov 03, 2023
18547489 METHODS OF ISOLATING EXOSOMES VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY GONZALEZ, MADELINE 1773 §103 Non-Final OA 36d overdue Pending Aug 22, 2023
18236327 T CELL RECEPTORS AND USES THEREOF Medigene Immunotherapies GmbH DIBRINO, MARIANNE 1641 §112 Non-Final OA 9d Pending Aug 21, 2023
18262469 ANALYZER AND METHOD FOR READING DETECTION RESULT OF TEST APPARATUS Leadway (Hk) Limited TURK, NEIL N 1798 §103 Non-Final OA 10d overdue Pending Jul 21, 2023
18262433 METHOD OF CHANGING CULTURE MEDIUM OF A CULTURE USING SPINFILTERS Repairon GmbH MARTIN, PAUL C 1653 §103 Non-Final OA 19d Pending Jul 21, 2023
18261995 NON-INVASIVE CANCER DETECTION BASED ON DNA METHYLATION CHANGES Nucleix Ltd. KIM, YOUNG J 1681 §103 Non-Final OA 13d Pending Jul 18, 2023
18255791 METHOD OF PRODUCING GLOBIN POLYPEPTIDE RECOMBINANTLY AND MEAT SUBSTITUTE FOOD PRODUCT Planeat Foods Pte. Ltd. PAK, YONG D 1652 §103 Non-Final OA 96d overdue Pending Jun 02, 2023
18253272 DETECTING METHYLATION CHANGES IN DNA SAMPLES USING RESTRICTION ENZYMES AND HIGH THROUGHPUT SEQUENCING Nucleix Ltd. VANN-OJUEKAIYE, KENDRA RAYCHELL 1682 §103 Non-Final OA 27d Pending May 17, 2023
18252489 LOOP MEDIATED ISOTHERMAL NUCLEIC ACID AMPLIFICATION (LAMP) USING LNA-MODIFIED PRIMERS AND A METAL-BASED COLORIMETRIC METHOD FOR DETECTING AN AMPLIFICATION PRODUCT Multiplexdx, S.R.O. YU, TIAN NMN 1681 §103 Non-Final OA 17d overdue Pending May 10, 2023
18036123 TEST DEVICE AND TEST PAPER Leadway (Hk) Limited JARRETT, LORE RAMILLANO 1797 §103 Non-Final OA 97d overdue Pending May 09, 2023
18114904 BLOOD PRESSURE-MONITORING SYSTEM WITH ALARM/ALERT SYSTEM THAT ACCOUNTS FOR PATIENT MOTION Sotera Wireless, Inc. JANG, CHRISTIAN Y 3791 §103 Non-Final OA 66d overdue Pending Feb 27, 2023
18092420 METHODS AND COMPOSITIONS FOR INCREASING EFFICIENCY OF TARGETED GENE MODIFICATION USING OLIGONUCLEOTIDE-MEDIATED GENE REPAIR Cibus Europe B.V. BOGGS, RUSSELL T 1663 Other Final Rejection 28d Pending Jan 02, 2023
17999185 MEK-INHIBITORS FOR THE TREATMENT OR PREVENTION OF CORONAVIRUS INFECTIONS AND/OR COVID-19 CYTOKINE STORM Atriva Therapeutics GmbH NESTOR, DONNA MICHELLE 1627 Other Final Rejection 89d overdue Pending Nov 17, 2022
17997009 METHOD FOR DETECTING HBV GENOTYPE, OLIGONUCLEOTIDE AND KIT Leadway (Hk) Limited PARKIN, JEFFREY S 1671 §103 Non-Final OA 30d overdue Pending Oct 24, 2022
17874198 FLEXIBLE SELF-POWERED MATERIALS FOR ON DEMAND GENERATION OF HYDROGEN PEROXIDE Wesbot, LLC EVANISKO, GEORGE ROBERT 3792 §103 Final Rejection 71d Pending Jul 26, 2022
17757211 AUTOMATED MEDIUM EXCHANGE STRATEGY FOR SUSPENSION CELLS Repairon GmbH MOSS, NATALIE M 1653 §103 Final Rejection 34d Pending Jun 10, 2022
17631845 A METHOD OF ELICITING AN IMMUNE RESPONSE BY ADMINISTERING A POPULATION OF POLYMERSOMES HAVING AN ASSOCIATED ANTIGEN TOGETHER WITH A POPULATION OF POLYMERSOMES HAVING AN ASSOCIATED ADJUVANT AS WELL AS COMPOSITIONS COMPRISING THE TWO POPULATIONS OF POLYMERSOMES Acm Biolabs Pte. Ltd. FOLEY, SHANON A 1671 §103 Final Rejection 30d Pending Jan 31, 2022
17576109 ANTI-SIRP ALPHA ANTIBODIES Sairopa B.V. BRISTOL, LYNN ANNE 1643 §112 Non-Final OA 9d Pending Jan 14, 2022
17617284 MICROFLUIDIC CHIP AND MANUFACTURING METHOD THEREFOR Leadway (Hk) Limited KASS, BENJAMIN JOSEPH 1798 §103 Non-Final OA 73d overdue Pending Dec 07, 2021
17617190 SYSTEM AND METHOD FOR REAL-TIME MULTICOLOR SHORTWAVE INFRARED FLUORESCENCE IMAGING The Regents of the University of California FAYE, MAMADOU 2884 §103 Final Rejection 74d overdue Pending Dec 07, 2021

Managing Acuity Law Group, P.C.'s Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month